Maryland Real Estate Roundup 2021

Collage with photos of Baltimore, Frederick, the Maryland flag, blue crabs, and text saying "Maryland Real Estate Roundup 2021"
Published on :

This year, Maryland continued to prove why it’s becoming one of the strongest biohealth clusters in the country. The state’s commitment to businesses in the life science, pharmaceutical, and biotech industries has continued as both the private and public sectors work to meet the demand for more space. Here are a few of the biggest real estate projects in Maryland in 2021. Some of these projects are still under construction, while others were unveiled this year. 

This University Startup Found Strong Support and Space Without Leaving Town

Published on :

Biomedical innovations can take a decade or more of ongoing research and development before they are ready to be used to treat patients. Even with funding and expert scientists, the most promising technologies can fail to go to market if entrepreneurs don’t have the experience or support to navigate the long and tedious drug development process.
A local resource is helping university-founded startups find success.
From a small lab space within the University of Maryland School of Medicine, Distinguished University Professor Vincent C.O. Njar, Ph.D., made an incredible discovery. Through his research, he developed novel small molecules with the potential to inhibit the growth of and treat breast cancer, with possible applications in dermatology and other types of cancer. Dr. Njar’s discovery could offer better outcomes for a range of patients.
To help clear the path to market, University of Maryland, Baltimore’s (UMB) New Ventures team worked with Dr. Njar to establish his startup, Isoprene Pharmaceuticals, Inc. The New Ventures program, run by a team with

Scheer Partners Releases BioHealth Capital Region Q3 Lab Market Report

Scheer Partners Lab Report Header
Published on :

Scheer Partners, a full-service commercial real estate firm headquartered in Rockville, Md and the leading provider of fully integrated commercial real estate services, recently published their Q3 Lab Markets Report for the Biohealth Capital Region, outlining the progress, challenges, and trends in the space.

This Baltimore-based Community Lab Makes Science Accessible to All

Collage with BUGSS logo and photos of participants
Published on :

Located in an industrial complex in East Baltimore’s Highlandtown, Baltimore Underground Science Space, popularly known as BUGSS, engages Baltimore community members in open dialogue and “learning through doing” as new biological technologies become more ingrained in our everyday lives.

LifeSprout Appoints Michael Kranda as CEO

Published on :

BALTIMORE–(BUSINESS WIRE)–LifeSprout, Inc., a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, today announced the appointment of Michael Kranda as CEO and member of the board of directors. 
“We’re pleased to have attracted an executive of Michael’s caliber to lead LifeSprout at this pivotal time for the company as we proceed to leverage the full potential of our regenerative cell therapy platform,” said Sashank Reddy, M.D., Ph.D., co-founder of LifeSprout.
“I welcome the opportunity to lead the LifeSprout team, and collaborate with the thought leaders in tissue engineering, nano biotechnology, and materials science from Johns Hopkins to establish a new standard of bio stimulatory products for cell therapy applications,” said Kranda, LifeSprout, Inc. CEO.

South Duvall and Sagamore Ventures Team Up to Bring High-End Lab Space to Baltimore’s Port Covington

Photo of City Garage in Baltimore
Published on :

Last week South Duvall and Sagamore Ventures announced that they have formed a partnership to bring more than 100,000 square feet of high-end laboratory space to City Garage in Baltimore’s Port Covington over the next ten years. Approximately 75,000 square feet of space is set to be delivered in the next year alone.

South Duvall and Sagamore Ventures to Bring Life Science to City Garage

Published on :

South Duvall and Sagamore Ventures today announced a  partnership to bring more than 100,000 square feet of biotech laboratory space to City Garage  in Port Covington, Baltimore, over the next ten years, with approximately 75,000 square feet  being delivered in the next year.

University of Maryland, Baltimore (UMB) Grants Pumas-AI Exclusive License of Analytics Platform to Enhance Drug Development

Published on :

Pumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights to enhancements to Pumas, an end-to-end pharmaceutical modeling and simulation platform for quantitative analysis across the drug development lifecycle. Pumas 2.0 builds on the company’s existing platform, which also employs technology licensed from UMB.

Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility

Published on :

Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) is allowing Emergent’s Bayview manufacturing facility to resume production of Johnson & Johnson’s (J&J) Covid-19 vaccine bulk drug substance. This resumption of manufacturing follows extensive reviews by FDA, weeks of diligent work, and close coordination with J&J and FDA to execute on Emergent’s quality enhancement plan.